Powered by
Weekly: Abattis Bioceuticals in its biggest weekly gain in 2 months
Feb 3, 2017 - News Bites Canadian Markets


Abattis Bioceuticals Corp. (CNSX:ATT), Canada's 42nd largest Biotechnology company by market cap, has lifted 1.50c (or 11.5%) in the past week to close at 14.50c. In the past week the shares have lifted 11.5%, the biggest weekly gain since December 16, 2016. Compared with the S&P/TSX 60 Index which fell 7.2 points (or 0.8%) in the week, this represented a relative price increase of 12.3%. The volume in the week equalled the average trading of 3.5 million shares

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox
Related News Feeds

Mentioned Entities

See how you can reach these people and organizations